[1] WADN J, FORSBLOM C, Thorn L M, et al. Adult stature and diabetes complications in patients with type 1 diabetes: The FinnDiane study and the diabetes control and complications trial[J]. Diabetes, 2009, 58(8): 1914-1920. [2] TONELLI M, MUNTNER P, LLOYD A, et al. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: A population-level cohort study[ J]. Lancet, 2012, 380(9844): 807-814. [3] Diabetes Prevention Program Research Group. Changes in albumin excretion in the Diabetes Prevention Program[J]. Diabetes Care, 2009, 32(4): 720-725. [4] National Kidney Foundation.KDOQI clinical practice guideline for diabetes and CKD: 2012 update[J]. American Journal of Kidney Diseases, 2012, 60(5): 850-886. [5] THORN L M, FORSBLOM C, WADN J, et al. Metabolic syndrome as a risk factor for cardiovascular disease, mortality, and progression of diabetic nephropathy in type 1 diabetes[J]. Diabetes Care, 2009, 32(5): 950-952. [6] SZADKOWSKA A,PIETRZAK I, MIANOWSKA B, et al. Insulin sensitivity in type 1 diabetic children and adolescents[J]. Diabetic Medicine, 2008, 25(3): 282-288. [7] LOVSHIN J A, KRTIC' M, PETTER B, et al. Hyperfiltration, urinary albumin excretion, and ambulatory blood pressure in adolescents with type 1 diabetes mellitus[J]. American Journal of Physiology-Renal Physiology, 2018, 314(4): F667-F674. [8] COSTACOU T, CRANDELL J, KAHKOSKA A R, et al. Dietary patterns over time and microalbuminuria in youth and young adults with type 1 diabetes: The SEARCH Nutrition Ancillary Study[J]. Diabetes Care, 2018, 41(8): 1615-1622. [9] MARCOVECCHIO M L, WOODSIDE J, JONES T, et al. Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT): Urinary screening and baseline biochemical and cardiovascular assessments[J]. Diabetes Care, 2014, 37: 805-813. [10] DEMIREL F, TEPE D, KARA O, et al. Microvascular complications in adolescents with type 1 diabetes mellitus[J]. Journal of Clinical Research in Pediatric Endocrinology, 2013, 5: 145-149. [11] DABELEA D, MAYER-DAVIS E J, SAYDAH S, et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009[J]. JAMA, 2014, 311(17): 1778-1786. [12] 严晋华, 章燕, 郑雪瑛,等. 1型糖尿病患者胰岛素治疗方案与血糖控制的相关性[J]. 中华医学杂志, 2017, 97(8): 587-591. YAN Jinhua, ZHANG Yan, ZHENG Xueying, et al.Insulin regimes and impact on glycemic control in patients with type 1 diabetes[J]. National Medical Journal of China, 2017, 97(8): 587-591. [13] EPSTEIN E J, OSMAN J L, COHEN H W, et al. Use of the estimated glucose disposal rate (eGDR) as a measure of insulin resistance in an urban multiethnic population with type 1 diabetes[J]. Diabetes Care, 2013, 36(8): 2280-2285. [14] ZHENG X , HUANG B , LUO S , et al. A new model to estimate insulin resistance via clinical parameters in adults with type 1 diabetes[J]. Diabetes/Metabolism Research and Reviews, 2017, 33(4):e2880. [15] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J].中华糖尿病杂志, 2018, 10(1): 4-67. [16] 中华医学会内分泌学分会肥胖学组. 中国成人肥胖症防治专家共识[J].中华内分泌代谢杂志, 2011, 27(9): 711-717. [17] SVENSSON M, YU Z W , ERIKSSON J W . A small reduction in glomerular filtration is accompanied by insulin resistance in type I diabetes patients with diabetic nephropathy[J]. European Journal of Clinical Investigation, 2002, 32(2): 100-109. [18] MOTTL A K, LAUER A, DABELEA D, et al. Albuminuria according to status of autoimmunity and insulin sensitivity among youth with type 1 and type 2 diabetes[J]. Diabetes Care, 2013, 36(11): 3633-3638. [19] MOTTL A K, DIVERS J, DABELEA D, et al. The dose-response effect of insulin sensitivity on albuminuria in children according to diabetes type[J]. Pediatric Nephrology, 2016, 31(6): 933-940. [20] 童国玉, 朱大龙. 糖尿病肾病国内外临床指南和专家共识解读[J].中国实用内科杂志, 2017(3):32-37. TONG Guoyu, ZHU Dalong.Interpretation of clinical practice guidelines and expert consensuses for the evaluation and management of diabetic kidney disease at home and abroad[J]. Chinese Journal of Practical Internal Medicine, 2017(3):32-37. [21] TUTTLE K R, BAKRIS G L, BILOUS R W, et al. Diabetic kidney disease: A report from an ADA Consensus Conference[J]. American Journal of Kidney Diseases, 2014, 64(4): 510-533. [22] WADN J, FORSBLOM C, THORN L M, et al. A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes[J]. Diabetes, 2009, 58(11): 2649-2655. [23] LITHOVIUS R, GORDIN D, FORSBLOM C, et al. Ambulatory blood pressure and arterial stiffness in individuals with type 1 diabetes[J]. Diabetologia, 2018, 61(9): 1935-1945.
() () |